biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by SOUTHFORKon Dec 16, 2002 8:42pm

454 Views

Post# 5683748

RE: INTEREST

Been watching this for awhile, like most others it's continuing the downward spiral, watching and waiting for an entry but things don't seem right. They just have too many shares outstanding for any serious considerations for M@A. The only way to bring in the real money they seem to need is for a rs and you know where that takes the current shareholders. Good Luck to all and happy holidays.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario